Rheumatism and musculoskeletal diseases (RMDs) include any diseases affecting joint, bone, spine, tendon, ligament or muscle. Because of this wide range of tissues involved in RMDs, these latter affect more than 120 million people throughout Europe. Acute and chronic pain, loss of mobility, disability, structural damage, impact on quality of life, on personal and professional relationships are the main concerns due to RMDs. Moreover, several RMDs are independent risk factors for cardiovascular comorbidities due to chronic inflammation and loss of physical activity participating in the metabolic syndrome. Taken together, it is obvious that these conditions are a huge problem in term of public health, by increasing the direct and indirect costs for a population. So, it is hard to understand why the awareness of RMDs among the public, politics and even the patients and their families themselves, remain quite low compared to other chronic conditions with a similar (and sometimes lower) impact on quality of life. This lecture will focus on the initiatives EULAR is developing in order to increase the awareness of RMDs at the national and international levels.
Disclosure of Interest None declared